Key market opportunities include rising demand for bioanalytical testing due to increased drug development, prevalence of ...

Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

Researchers at the University of Plymouth are leading an innovative initiative to advance the study of meningiomas in NF2-related schwannomatosis (NF2-SWN). Meningiomas, often linked to the loss of ...

MED Institute, a leader in pre-clinical and clinical medical product development services, is proud to announce a strategic collaboration with Sus Clinicals, a pioneering provider of genetic-modified ...

NAMSA has acquired select assets of Labcorp’s early development medical device testing business, aligning with .

Plasma phosphorylated (p)-tau217 testing can help identify preclinical Alzheimer's disease (AD), which could aid clinical trial recruitment. Recruiting preclinical AD participants for clinical ...

HOUSTON, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (BPTH),, a biotechnology company leveraging its proprietary DNAbilize ® liposomal delivery and antisense technology to develop a ...

Approximately 75% of anticancer drugs must be tested against paediatric cancer. Drug developers can now use a database of patient-derived tumour models to screen their products for paediatric cancer ...